ArticleMembranes2026
Extracellular Polymeric Substance-Intercalated MXene Membranes Toward Removal of Emerging Contaminants.
Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Resource recovery from excess sludge, specifically the extraction of extracellular polymeric substances (EPSs), has become a frontier issue; yet achieving high-value utilization of this recovered resource remains a key bottleneck. Two-dimensional MXene membranes show great potential for emerging contaminants (ECs) separation owing to their lamellar structure and tunable surface chemistry. In this study, biological macromolecule (BM)-intercalated MXene (BM-M) composite membranes were fabricated using practical EPSs and model EPSs such as sodium alginate (SA), bovine serum albumin (BSA), and silk fibroin (SF) as sustainable intercalators. The interlayer spacing, surface charge, hydrophilicity, mechanical strength, functional group of BM-M membranes and their EC removal behaviors were systematically investigated. The practical EPS performed better than the model EPS, highlighting the importance of molecular complexity in interlayer design. The practical EPS-intercalated MXene (EPS-M) membrane achieved the removal efficiencies of 64.0%, 90.2% and 67.5% for diethyl phthalate (DEP), erythromycin (ERY) and sulfamethoxazole (SMX), respectively. The separation mechanism of ECs mainly included electrostatic, sieving, hydrophobic, and hydrogen bonding. This work highlights the effectiveness of EPS intercalation in tailoring MXene membrane structure for the removal of diverse ECs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.